title: Hepatitis B virus: the importance of age at infection.
abstract: Recent studies have demonstrated the importance of age at infection with hepatitis B virus (HBV). Age affects whether the infection is self-limited or results in the chronic carrier state, the severity of the acute infection, and the incidence of various sequelae of the chronic carrier state. In particular, although the acute infection is more severe in adults, infections in infants and preschool children carry much greater risks of chronic carriage which increases the risk of primary hepatocellular carcinoma and cirrhosis later in life. This has two important implications for areas where HBV is endemic. First, more impact can be gained by vaccinating infants and preschool children than by vaccinating healthy adults. Second, if funds are limited, greater impact will be gained by immunising a larger number of children with low doses of vaccine so that they are protected during the early years of life when the risk of chronic carriage is highest, rather than using the standard dose in a smaller number of children even though protection may be longer lasting with standard doses. These two considerations provide the basis for an efficient strategy for control in communities or countries where HBV is endemic or hyperendemic.
authors.affiliation: Department of Community Health, Wellington School of Medicine.
authors.forename: N
authors.initials: N
authors.lastname: Pearce
authors.forename: A
authors.initials: A
authors.lastname: Milne
authors.forename: C
authors.initials: C
authors.lastname: Moyes
mesh_terms: D000293:Adolescent; D000367:Age Factors; D002353:Carrier State / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D006509:Hepatitis B / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D017325:Hepatitis B Vaccines; D006801:Humans; D007223:Infant; D009520:New Zealand; D012307:Risk Factors; D014761:Viral Hepatitis Vaccines
chemical_list: D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines